Login or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Tekes K1. Basic aspects of the pharmacodynamics of tolperisone, a widely applicable centrally acting muscle relaxant. Open Med Chem J. 2014;11:17–22.
Quasthoff S, Möckel C, Zieglgänsberger W, et al. Tolperisone: a typical representative of a class of centrally acting muscle relaxants with less sedative side effects. CNS Neurosci Ther. 2008;14:107–19.
Pratzel HG, Alken RG, Ramm S. Efficacy and tolerance of repeated oral doses of tolperisone hydrochloride in the treatment of painful reflex muscle spasm: results of a prospective placebo-controlled double-blind trial. Pain. 1996;67:417–25.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Tsokolas, G., Almuhtaseb, H., Hanifudin, A. et al. Tolperisone, a centrally-acting muscle relaxant: a possible cause of macular haemorrhage. Eye 34, 1380–1381 (2020). https://doi.org/10.1038/s41433-019-0578-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41433-019-0578-9
This article is cited by
-
Tolperisone
Reactions Weekly (2020)